Fenofibrate delays the need for dialysis and reduces cardiovascular risk among patients with advanced CKD
Journal of Clinical Endocrinology and Metabolism | Mar 09, 2021
Cardiovascular disease risk factors and metabolic morbidity in a longitudinal study of congenital adrenal hyperplasia
Journal of Clinical Endocrinology and Metabolism | Mar 09, 2021
Fasting plasma GLP-1 associates with overweight/obesity and cardiometabolic risk factors in children and adolescents
Journal of Clinical Endocrinology and Metabolism | Feb 23, 2021
Most read this week